Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma-Reference-Cited by-同舟云学术

Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myeloma

Published:2008-03-10 Issue:6 Volume:80 Page:490-494
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:

Author:

Kaiser Martin,Mieth Maren,Liebisch Peter,Oberländer Romy,Rademacher Jessica,Jakob Christian,Kleeberg Lorenz,Fleissner Claudia,Braendle Edgar,Peters Malte,Stover David,Sezer Orhan,Heider Ulrike

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-0609.2008.01065.x/fullpdf

Reference26 articles.

1. An international field study of the reliability and validity of a disease-specific questionnaire module (the QLQ-MY20) in assessing the quality of life of patients with multiple myeloma;Cocks;Eur J Cancer,2007

2. Myeloma bone disease and proteasome inhibition therapies;Terpos;Blood,2007

3. Novel aspects of osteoclast activation and osteoblast inhibition in myeloma bone disease;Heider;Biochem Biophys Res Commun,2005

4. Immunocytochemistry reveals RANKL expression of myeloma cells;Sezer;Blood,2002

5. Human bone marrow myeloma cells express RANKL;Sezer;J Clin Oncol,2002

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dickkopf-1 and ROCK2 upregulation and associated protein aggregation in pseudoexfoliation syndrome and glaucoma;Life Sciences;2023-08

2. Dynamics of Bone Disease Biomarkers Dickkopf-1 and Sclerostin in Patients with Multiple Myeloma;Journal of Clinical Medicine;2023-07-01

3. Construction and evaluation of an aging-associated genes-based model for pancreatic adenocarcinoma prognosis and therapies;International Journal of Immunopathology and Pharmacology;2023-04-18

4. Myeloma bone disease: pathogenesis and management in the era of new anti-myeloma agents;Journal of Bone and Mineral Metabolism;2023-03-01

5. New Emerging Biomarkers for Bone Disease: Sclerostin and Dickkopf-1 (DKK1);Calcified Tissue International;2022-09-27